Back to MW MARSHALL WACE, LLP

ROIVROIV

Showing 8 of 16 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ROIVANT SCIENCES LTD

Yes. Marshall Wace holds 1,421,478 shares of ROIV (Roivant Sciences), worth $50.3M, as of its Q2 2026 13F filing. It reduced the position by 825,465 shares (-36.7%) from Q1 2026. Marshall Wace has held ROIV since Q4 2023, across 11 quarterly 13F filings.

Current Value

$50.3M

Current Shares

1.4M

Total Value Change

+$33.7M

Total Shares Change

-20,414

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.4M
-36.7%
$50.3M0.0%$35.39
0
2026-Q1
Decreased
2.2M
-35.0%
$62.2M0.1%$27.85
0
2025-Q4
Decreased
3.5M
-13.1%
$75.1M0.1%$21.63
0
2025-Q3
Increased
4M
+316.5%
$60.2M0.1%$15.10
48
2025-Q2
Increased
955,150
+251.4%
$10.8M0.0%$11.39
45
2025-Q1
Decreased
271,823
-90.8%
$2.7M0.0%$10.38
0
2024-Q4
Increased
2.9M
+104.4%
$34.9M0.0%$11.43
47
2024-Q3
Increased
1.4M
+101.7%
$16.6M0.0%$11.48
46

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used